Found: 40
Select item for more details and to access through your institution.
Incidence and Management of Immune-Related Adverse Events in Patients Undergoing Treatment with Immune Checkpoint Inhibitors.
- Published in:
- Current Oncology Reports, 2018, v. 20, n. 3, p. 1, doi. 10.1007/s11912-018-0671-4
- By:
- Publication type:
- Article
Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Keeping an Eye Out for Immunotherapy Toxicity: A Case of Unilateral Ptosis Caused by Ipilimumab/Nivolumab Therapy.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 2, p. 126, doi. 10.36401/JIPO-23-44
- By:
- Publication type:
- Article
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 1, p. 1, doi. 10.36401/JIPO-23-20
- By:
- Publication type:
- Article
Pilot Evaluation of Flaxseed for the Management of Hot Flashes.
- Published in:
- Journal of the Society for Integrative Oncology, 2007, v. 5, n. 3, p. 106, doi. 10.2310/7200.2007.007
- By:
- Publication type:
- Article
Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45798-8
- By:
- Publication type:
- Article
Sinonasal mucosal melanoma: An analysis of treatment‐related adverse events and associated factors.
- Published in:
- International Forum of Allergy & Rhinology, 2023, v. 13, n. 6, p. 1037, doi. 10.1002/alr.23118
- By:
- Publication type:
- Article
In-Transit Melanoma: An Individualized Approach.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 14, p. 1340
- By:
- Publication type:
- Article
Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Immune Checkpoint Inhibitor-Induced Thyroiditis Is Associated with Increased Intrathyroidal T Lymphocyte Subpopulations.
- Published in:
- Thyroid, 2020, v. 30, n. 10, p. 1440, doi. 10.1089/thy.2020.0075
- By:
- Publication type:
- Article
PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer Patients.
- Published in:
- Thyroid, 2020, v. 30, n. 2, p. 177, doi. 10.1089/thy.2019.0250
- By:
- Publication type:
- Article
Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 10, p. 2203, doi. 10.1002/cam4.1152
- By:
- Publication type:
- Article
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1279387
- By:
- Publication type:
- Article
Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0230306
- By:
- Publication type:
- Article
Combination of paclitaxel and carboplatin as second‐line therapy for patients with metastatic melanomaData previously presented at the annual meeting of the American Society of Clinical Oncology, Orlando, Florida, May 13–17, 2005.Institutional review board (IRB) permission was obtained for this analysis. The medical records of patients who refused research authorization were excluded from our study.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 2, p. 375
- By:
- Publication type:
- Article
The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 4, p. 1185, doi. 10.1007/s00520-012-1647-9
- By:
- Publication type:
- Article
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Response to letter to the editor referencing manuscript the 'Use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial'.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Levetiracetam for the treatment of hot flashes: a phase II study.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Neoadjuvant systemic therapy for regionally advanced melanoma.
- Published in:
- Journal of Surgical Oncology, 2018, v. 117, n. 6, p. 1164, doi. 10.1002/jso.24939
- By:
- Publication type:
- Article
The role of serum lactate dehydrogenase level as a prognostic indicator in resected, high risk melanoma.
- Published in:
- Dermatologic Therapy, 2019, v. 32, n. 2, p. N.PAG, doi. 10.1111/dth.12813
- By:
- Publication type:
- Article
Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Rheumatic Syndromes Associated With Immune Checkpoint Inhibitors: A Single‐Center Cohort of Sixty‐One Patients.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 3, p. 468, doi. 10.1002/art.40745
- By:
- Publication type:
- Article
Brief Report: Cancer Immunotherapy in Patients With Preexisting Rheumatic Disease: The Mayo Clinic Experience.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 3, p. 356, doi. 10.1002/art.40397
- By:
- Publication type:
- Article
The Dark Side of Immunotherapy: Managing Adverse Events from Immune Checkpoint Inhibitors.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2020, v. 11, n. 12, p. 470
- By:
- Publication type:
- Article
Nursing Knowledge, Practice Patterns, and Learning Preferences Regarding Chemotherapy-Induced Peripheral Neuropathy.
- Published in:
- Oncology Nursing Forum, 2014, v. 41, n. 6, p. 669, doi. 10.1188/14.ONF.669-679
- By:
- Publication type:
- Article
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance).
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 22, p. 3575, doi. 10.1002/cncr.28892
- By:
- Publication type:
- Article
A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 3, p. 586, doi. 10.1002/cncr.27760
- By:
- Publication type:
- Article
A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group Study, N057E(1).
- Published in:
- 2011
- By:
- Publication type:
- journal article
A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 8, p. 1704, doi. 10.1002/cncr.25659
- By:
- Publication type:
- Article
Phase 2 Trial of Carboplatin, Weekly Paclitaxel, and Biweekly Bevacizumab in Patients With Unresectable Stage IV Melanoma: A North Central Cancer Treatment Group Study, N047A.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 1, p. 119, doi. 10.1002/cncr.23987
- By:
- Publication type:
- Article
Sex Differences in Tolerability to Anti‐Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non‐Small Cell Lung Cancer: Are We All Equal?
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1148, doi. 10.1634/theoncologist.2019-0094
- By:
- Publication type:
- Article
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort.
- Published in:
- Journal of Women's Health (15409996), 2020, v. 29, n. 9, p. 1160, doi. 10.1089/jwh.2019.7851
- By:
- Publication type:
- Article
Triple M Syndrome: Implications for Hematology-Oncology Advanced Practice Providers.
- Published in:
- Clinical Journal of Oncology Nursing, 2023, v. 27, n. 5, p. 463, doi. 10.1188/23.CJON.463-467
- By:
- Publication type:
- Article
Promoting Oral Therapy Adherence: Consensus statements from the faculty of the Melanoma Nursing Initiative on oral melanoma therapies.
- Published in:
- Clinical Journal of Oncology Nursing, 2017, v. 21, n. 4, p. 87, doi. 10.1188/17.CJON.S4.87-96
- By:
- Publication type:
- Article